Chemours Co
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
A federal judge ruled Chemours and DuPont liable for PFAS contamination on properties of 180,000+ North Carolinians. The March 2027 trial will focus on damages, not liability. The lawsuit seeks compensation for water-related expenses. The companies did not comment.
Cumberland County is nearing a settlement with Chemours and DuPont over PFAS contamination. The trial was canceled, and details are confidential. According to Veronica Jones, the settlement is favorable. The county's board will discuss it further. Chemours and DuPont were found liable for pollution from the Fayetteville Works plant.
Chemours is entering the data center market with a PFAS-based refrigerant, Opteon 2P50, to reduce energy and water use. The EPA is reviewing the chemical, which is not yet commercially available in the U.S. Local officials are debating the future of data centers due to environmental concerns, with some implementing moratoriums.
Over the past 7 days, alphai's AI scored 3 news stories mentioning CC (Chemours Co). Coverage has skewed bearish: 0 bullish, 2 neutral, and 1 bearish.
Recent CC coverage spans regulation, financial news and insider activity.
In the last 30 days, CC insiders filed 2 SEC Form 4 transactions — 2 purchases ($81K) and no sales. The most active reporter was Dignam Denise, Chief Executive Officer, with 1 filing.
Negative legal exposure may pressure Chemours stock.
Potential settlement could lead to a cash outflow or liability adjustment for Chemours.
Potential environmental concerns may affect Chemours' stock perception; EPA approval could unlock a new market.
Potential financial liability and reputational risk for Chemours.
Potential modest upside if price moves toward target.
alphai scores every news story that mentions CC with an AI model for sentiment and relevance, and aggregates insider trades from Chemours Co's SEC EDGAR Form 4 filings. Figures refresh continuously.
A federal judge ruled Chemours and DuPont liable for PFAS contamination on properties of 180,000+ North Carolinians. The March 2027 trial will focus on damages, not liability. The lawsuit seeks compensation for water-related expenses. The companies did not comment.
2 min readCumberland County is nearing a settlement with Chemours and DuPont over PFAS contamination. The trial was canceled, and details are confidential. According to Veronica Jones, the settlement is favorable. The county's board will discuss it further. Chemours and DuPont were found liable for pollution from the Fayetteville Works plant.
2 min readChemours is entering the data center market with a PFAS-based refrigerant, Opteon 2P50, to reduce energy and water use. The EPA is reviewing the chemical, which is not yet commercially available in the U.S. Local officials are debating the future of data centers due to environmental concerns, with some implementing moratoriums.
2 min readA federal court ruled that Chemours and DuPont are liable for PFAS contamination in North Carolina, but class certification is still under review. The ruling was made on August 24 by Judge James C. Dever III.
2 min readAnalysts Hassan Ahmed and John McNulty maintained Buy ratings on Chemours (CC) and Solstice Advanced Materials (SOLS), with price targets of $22.00 and $95.00 respectively. CC closed at $15.42, near its 52-week low, while SOLS closed at $60.09. Analyst consensus for CC is Moderate Buy ($19.78 avg. target), and for SOLS is Strong Buy ($80.17 avg. target).
1 min readChemours director Mary B. Cranston bought 6,000 shares of The Chemours Company (CC) on Aug. 7, 2026 at $15.825 each for $94,950. Post-trade, her beneficial ownership is 113,140.9469 shares. The article also cites Chemours Q2 results of $0.42 EPS on $1.59B revenue, and a UBS downgrade to Neutral with a $18 target from $29.
3 min readChemours insider Michael Robert Foley, president of Titanium Technologies, bought 1,934.2313 shares of Chemours (NYSE:CC) on Aug. 7, 2026 for about $29,999 at $15.51 to $15.54 per share. The purchase follows Q2 2026 results of $0.42 EPS on $1.59B revenue, below estimates, and a UBS downgrade to Neutral with a $18 target.
2 min readChemours (CC) launched ultra-low and low-GWP Opteon ZE (R-1234ze(E)) and Opteon 515B (R-515B) for stationary chillers and AI data center cooling. The article links the expansion to Chemours’ regulatory-driven refrigerant growth narrative but notes weak Opteon aftermarket demand, PFAS liabilities, and interest costs. It cites a 2026 net loss outlook of $255m to $230m and longer-term targets of $6.8b revenue and $1.3b earnings by 2029.
6 min readFamiliar Calderon Gerardo (See Remarks) purchased 1,935 shares of Chemours Co (CC) at $15.53 on 2026-08-12.
1 min readDignam Denise (Chief Executive Officer) purchased 3,378 shares of Chemours Co (CC) at $14.95 on 2026-08-11.
2 min read
